SCHEMBL7749005

SCHEMBL7749005

CCc1cc(-c2ccc(F)cc2)c(O)cc1OCCCOc1ccccc1/C=C/C(=O)O

nearest known ligand 0.67

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LTB4R Q15722 20/20 0.67
LTB4R2 Q9NPC1 18/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7749010 1.00 LTB4R (0.67) LTB4RLTB4R2
SCHEMBL27589435 0.89 LTB4R (0.56) LTB4RLTB4R2
SCHEMBL8568850 0.88 LTB4R (0.52) LTB4RLTB4R2
SCHEMBL8568854 0.88 LTB4R (0.52) LTB4RLTB4R2
SCHEMBL8563583 0.87 LTB4R (0.52) LTB4RLTB4R2
SCHEMBL8563579 0.87 LTB4R (0.52) LTB4RLTB4R2
SCHEMBL8562389 0.84 LTB4R (0.66) LTB4RLTB4R2
SCHEMBL8562386 0.84 LTB4R (0.66) LTB4RLTB4R2
SCHEMBL8561890 0.80 LTB4R (1.00) LTB4RLTB4R2
SCHEMBL8563513 0.78 LTB4R (0.65) LTB4RLTB4R2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001034198-A2 ONCOLYTIC COMBINATIONS FOR THE TREATMENT OF CANCER ELI LILLY AND COMPANY (US) 2001-05-17 WO claimed
EP-0544488-B1 Substituted phenyl phenol leukotriene antagonists LILLY CO ELI (US) 1998-03-11 EP disclosed
WO-1996036347-A1 USE OF LEUKOTRIENE ANTAGONISTS FOR ALZHEIMER'S DISEASE ELI LILLY AND COMPANY (US) 1996-11-21 WO disclosed
EP-0743064-A1 Leukotriene antagonists for use in the treatment or prevention of alzheimer's disease ELI LILLY AND COMPANY (US) 1996-11-20 EP disclosed
US-5462954-A Antiinflammatory, antiallergens; treating asthma ELI LILLY AND COMPANY (US) 1995-10-31 US disclosed
EP-0544488-A2 Substituted phenyl phenol leukotriene antagonists ELI LILLY AND COMPANY (US) 1993-06-02 EP disclosed